Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Metronomic Cyclophosphamide in Metastatic Head and Neck Cancer
NCT01581970Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jun 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in head and neck squamous cell carcinoma (HNSCC), sponsored by Masonic Cancer Center. Started Jun 2012; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01581970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581970.